- Home
- AXDX vs VRAR Comparison
AXDX vs VRAR Comparison
Compare AXDX & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- VRAR
- Stock Information
- Founded
- AXDX 1982
- VRAR 2016
- Country
- AXDX United States
- VRAR United States
- Employees
- AXDX N/A
- VRAR N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- VRAR Retail: Computer Software & Peripheral Equipment
- Sector
- AXDX Industrials
- VRAR Technology
- Exchange
- AXDX Nasdaq
- VRAR Nasdaq
- Market Cap
- AXDX 13.7M
- VRAR N/A
- IPO Year
- AXDX 1996
- VRAR 2021
- Fundamental
- Price
- AXDX $0.14
- VRAR $1.16
- Analyst Decision
- AXDX
- VRAR Strong Buy
- Analyst Count
- AXDX 0
- VRAR 1
- Target Price
- AXDX N/A
- VRAR $2.62
- AVG Volume (30 Days)
- AXDX 425.6K
- VRAR 75.5K
- Earning Date
- AXDX 05-16-2025
- VRAR 05-19-2025
- Dividend Yield
- AXDX N/A
- VRAR N/A
- EPS Growth
- AXDX N/A
- VRAR N/A
- EPS
- AXDX N/A
- VRAR 0.86
- Revenue
- AXDX $11,698,000.00
- VRAR $591,251,000.00
- Revenue This Year
- AXDX $7.25
- VRAR N/A
- Revenue Next Year
- AXDX N/A
- VRAR $30.43
- P/E Ratio
- AXDX N/A
- VRAR N/A
- Revenue Growth
- AXDX N/A
- VRAR N/A
- 52 Week Low
- AXDX $0.12
- VRAR $0.50
- 52 Week High
- AXDX $2.09
- VRAR $7.00
- Technical
- Relative Strength Index (RSI)
- AXDX 14.62
- VRAR 48.31
- Support Level
- AXDX $0.50
- VRAR $1.09
- Resistance Level
- AXDX $0.56
- VRAR $1.20
- Average True Range (ATR)
- AXDX 0.05
- VRAR 0.07
- MACD
- AXDX -0.01
- VRAR 0.01
- Stochastic Oscillator
- AXDX 4.44
- VRAR 64.00
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.